That's a private member's bill we're talking about. What I was thinking is that this committee is master of its own business.
It's always been my understanding that government legislation takes priority. Even then, it's still up to the committee to decide. By convention, government legislation would certainly take priority over studies, but I'm not so sure that a private member's bill takes priority over a motion of this committee that we could determine is of broader significance.
In my opinion, we should be looking at which motion we think is of more serious implication for health in Canada, which may be more timely.
I want to say that the story I heard on the radio a couple of weeks ago was extremely alarming. There is some talk that there are now bacteria that are resistant to all forms of antibiotics. If they make their way into Canada, we could be seeing a widespread public health emergency.
With great respect for Todd's PMB on post-traumatic stress disorder, of course that's important and we should get at it, but I don't see it necessarily taking priority.
I would also point out again that my motion is a year old, so something has to wait. I don't see why Mr. Doherty's bill can't wait an extra few months. There is no reason we couldn't pick that up and study it in the fall.
We also have to be very alert and alive to the fact that there could be government legislation that comes to this committee that we would have to put in front of other business. I think that the study of antimicrobial resistance should commence.